| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000253397.42079.D5 |
| P698 | PubMed publication ID | 17205009 |
| P2093 | author name string | Avi Porath | |
| Victor Novack | |||
| Lena Novack | |||
| Harel Gilutz | |||
| Yaniv Almog | |||
| Miruna Eisinger | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 372-378 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases | |
| P478 | volume | 35 |
| Q43735742 | An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006. |
| Q37287361 | Chronic Statin Use and Long-Term Rates of Sepsis: A Population-Based Cohort Study |
| Q28276884 | Confronting an influenza pandemic with inexpensive generic agents: can it be done? |
| Q41443349 | Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis |
| Q35077842 | Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study |
| Q40378887 | Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia |
| Q35579498 | Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance |
| Q58584684 | Improved survival with continuation of statins in bacteremic patients |
| Q40390498 | Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. |
| Q64913412 | Optimal duration for continuation of statin therapy in bacteremic patients. |
| Q99404616 | Pathways in the Pathophysiology of Coronavirus 19 Lung Disease Accessible to Prevention and Treatment |
| Q30402302 | Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease |
| Q33919029 | Preadmission statin use and one-year mortality among patients in intensive care - a cohort study |
| Q35007498 | Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome |
| Q37778307 | Propensity scores in intensive care and anaesthesiology literature: a systematic review |
| Q34559446 | Rosuvastatin for sepsis-associated acute respiratory distress syndrome |
| Q33859429 | Simvastatin treatment improves survival in a murine model of burn sepsis: Role of interleukin 6 |
| Q43111774 | Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria |
| Q34612901 | Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study |
| Q37612800 | Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study |
| Q33587600 | Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis |
| Q30375212 | Statin treatment and mortality: propensity score-matched analyses of 2007-2008 and 2009-2010 laboratory-confirmed influenza hospitalizations. |
| Q37229844 | Statin use and risk of community acquired pneumonia in older people: population based case-control study |
| Q36117003 | Statin use and the risk of Clostridium difficile in academic medical centres |
| Q37956128 | Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies |
| Q34086279 | Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials |
| Q36797719 | Statins and sepsis: multiple modifications at multiple levels. |
| Q51864833 | Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. |
| Q41426439 | Statins enhance formation of phagocyte extracellular traps |
| Q24235104 | Statins for influenza and pneumonia |
| Q94328795 | Statins for influenza and pneumonia |
| Q36369699 | Statins in the critically ill |
| Q59349662 | Statins: a viable candidate for host-directed therapy against infectious diseases |
| Q34531972 | Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality |
| Q35687032 | The Effects of Statins on Infections after Stroke or Transient Ischemic Attack: A Meta-Analysis |
| Q34247532 | The effect of rosuvastatin in a murine model of influenza A infection |
| Q35894584 | The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial |
| Q36876210 | The effect of statin therapy on the incidence of infections: a retrospective cohort analysis. |
| Q46127227 | The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial |
| Q80697200 | [Microcirculation of intensive care patients. From the physiology to the bedside] |
Search more.